JPH0753323A - Photosetting packing material for tooth - Google Patents
Photosetting packing material for toothInfo
- Publication number
- JPH0753323A JPH0753323A JP5222133A JP22213393A JPH0753323A JP H0753323 A JPH0753323 A JP H0753323A JP 5222133 A JP5222133 A JP 5222133A JP 22213393 A JP22213393 A JP 22213393A JP H0753323 A JPH0753323 A JP H0753323A
- Authority
- JP
- Japan
- Prior art keywords
- component
- packing material
- photosetting
- magnesium oxide
- filling material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Dental Preparations (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、裏層剤や覆罩剤として
の使用に適した歯牙用光硬化性充填材料に関するもので
ある。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a photocurable filling material for teeth which is suitable for use as a backing agent or a covering agent.
【0002】[0002]
【従来の技術】歯科保存の分野においては、歯髄を保護
し、その機能を維持させる目的で、露出した歯髄を直接
に薬剤(覆罩剤)で被覆する直接覆髄法や、1層の歯質
を隔てて歯髄を間接的に薬剤(裏層剤)で被覆する間接
覆髄法が行われてきており、これらの歯髄覆罩法におい
ては、歯髄を被覆する薬剤(覆髄剤)として水酸化カル
シウム製剤が広く使用されてきている。このような水酸
化カルシウム製剤としては、水酸化カルシウム単味や水
酸化カルシウムセメント等があり、これらの水酸化カル
シウム製剤中に含有されている水酸化カルシウム(Ca
(OH)2 )は、鎮静効果を示すだけでなく、庇蓋硬組
織の形成を促進させるという利点を有する。2. Description of the Related Art In the field of dental preservation, in order to protect the pulp and maintain its function, the direct pulp capping method in which the exposed pulp is directly coated with a drug (covering agent), or a single-layer tooth is used. An indirect pulp capping method has been performed in which the pulp is indirectly coated with a drug (lining agent) across the quality. In these pulp pulping methods, water is used as a drug (capsule covering agent) for coating the pulp. Calcium oxide formulations have been widely used. Examples of such calcium hydroxide preparations include calcium hydroxide alone and calcium hydroxide cement, and the calcium hydroxide (Ca) contained in these calcium hydroxide preparations.
(OH) 2 ) not only has a sedative effect, but also has the advantage of promoting the formation of eaves hard tissue.
【0003】しかしながら、この水酸化カルシウムは強
いアルカリ性を示す物質であるために、水酸化カルシウ
ムを歯牙用のラジカル重合性樹脂中に混合して得た充填
材料を、裏層剤や覆罩剤として使用した場合には、樹脂
の安定性が損なわれ、特に光硬化性の経時低下が観察さ
れたり、得られる硬化物の圧縮強度が経時劣化する等の
問題点があった。However, since this calcium hydroxide is a substance exhibiting a strong alkalinity, a filler obtained by mixing calcium hydroxide with a radically polymerizable resin for teeth is used as a backing agent or a covering agent. When it is used, there are problems that the stability of the resin is impaired, a decrease in photocurability with time is observed, and the compression strength of the obtained cured product deteriorates with time.
【0004】これまで、水酸化カルシウム製剤と同等の
歯髄保護効果を有し、かつラジカル重合性樹脂の経時安
定性に影響を及ぼすことがない充填剤を含む歯牙用光硬
化性充填材料は提案されていない。To date, photocurable filling materials for teeth have been proposed which have a pulp protection effect equivalent to that of calcium hydroxide preparations and which do not affect the temporal stability of the radical-polymerizable resin. Not not.
【0005】[0005]
【発明が解決しようとする課題】本発明の課題は、前述
の問題点を解決し、水酸化カルシウム製剤と同等の歯髄
保護効果を示し、かつ光重合性樹脂の安定性に悪影響を
及ぼさないような充填剤を含有する歯牙用光硬化性充填
材料を提供することにある。SUMMARY OF THE INVENTION The object of the present invention is to solve the above-mentioned problems, to show a pulp protecting effect equivalent to that of a calcium hydroxide preparation, and to prevent the stability of the photopolymerizable resin from being adversely affected. Another object of the present invention is to provide a photocurable filling material for teeth containing a different filler.
【0006】[0006]
【課題を解決するための手段】本発明の歯牙用光硬化性
充填材料は、 成分A:ラジカル重合性不飽和単量体、 成分B:光増感剤、及び 成分C:充填剤 を含む歯牙用光硬化性充填材料において、前記成分Cと
して、少なくとも酸化マグネシウム粉末を含むこと、及
び、前記歯牙用光硬化性充填材料全体における前記酸化
マグネシウム粉末の重量割合が2〜60重量%であるこ
とを特徴とする。The photo-curable filling material for teeth of the present invention is a tooth containing component A: radically polymerizable unsaturated monomer, component B: photosensitizer, and component C: filler. In the photocurable filling material for dental use, at least magnesium oxide powder is contained as the component C, and the weight ratio of the magnesium oxide powder in the whole photocurable filling material for teeth is 2 to 60% by weight. Characterize.
【0007】即ち、本発明の歯牙用光硬化性充填材料
は、従来より知られている充填材料の構成成分(ラジカ
ル重合性不飽和単量体、光増感剤、及び充填剤)をいず
れも含むものであるが、このうちの充填剤としての必須
成分が酸化マグネシウム粉末であって、しかも、この酸
化マグネシウム粉末の、歯牙用光硬化性充填材料全体に
おける重量割合が一定の範囲内であることを特徴とす
る。本発明では、成分Cとして含有される酸化マグネシ
ウム粉末の含有量が、歯牙用光硬化性充填材料全体の2
〜60重量%であり、10〜40重量%の範囲が特に好
ましい。もし酸化マグネシウム粉末の含有量が2重量%
以下の場合には、鎮静、庇蓋硬組織の形成促進、刺激遮
断などの効果が小さくなり、逆に、酸化マグネシウム粉
末の含有量が60重量%以上の場合には、充填材料全体
における樹脂成分(成分A)の割合が小さくなって充填
材料の硬化性能が低下する。本発明では、このような酸
化マグネシウム粉末として市販品、例えば日本薬局方の
酸化マグネシウムを処理せずにそのまま利用することも
できるが、チタネート処理やシランカップリング処理等
により表面処理しても良い。That is, the photocurable filling material for teeth of the present invention includes all the constituents of the conventionally known filling material (radical-polymerizable unsaturated monomer, photosensitizer, and filler). Of these, the essential component of the filler is magnesium oxide powder, and the weight ratio of the magnesium oxide powder to the entire photocurable filling material for teeth is within a certain range. And In the present invention, the content of the magnesium oxide powder contained as the component C is 2% of the whole photocurable filling material for teeth.
-60% by weight, with a range of 10-40% by weight being particularly preferred. If the content of magnesium oxide powder is 2% by weight
In the following cases, the effects such as sedation, promotion of eaves lid hard tissue formation, and stimulation block are reduced. Conversely, when the content of magnesium oxide powder is 60% by weight or more, the resin component in the entire filling material is reduced. The ratio of (Component A) becomes small and the curing performance of the filling material decreases. In the present invention, as such a magnesium oxide powder, a commercially available product, for example, magnesium oxide of the Japanese Pharmacopoeia can be used as it is without treatment, but it may be surface-treated by titanate treatment, silane coupling treatment, or the like.
【0008】本発明の歯牙用光硬化性充填材料に含有さ
れる酸化マグネシウム粉末は、優れた庇蓋硬組織形成能
を示すので、本発明の充填材料を使用することにより、
歯髄の状態を維持し保存することができる。しかも、こ
の酸化マグネシウム粉末は、従来の水酸化カルシウムの
ような強アルカリ性の物質でないために、ラジカル重合
性不飽和単量体の経時安定性が悪影響を受けることもな
い。Since the magnesium oxide powder contained in the photocurable filling material for teeth of the present invention exhibits an excellent eaves lid hard tissue forming ability, by using the filling material of the present invention,
The condition of the dental pulp can be maintained and preserved. Moreover, since this magnesium oxide powder is not a strongly alkaline substance such as conventional calcium hydroxide, the temporal stability of the radically polymerizable unsaturated monomer is not adversely affected.
【0009】一方、成分Aとして含有されるラジカル重
合性単量体としては、市販の歯科用重合性樹脂が各種利
用できるが、メタクリル酸エステル系ビニルモノマーや
アクリル酸エステル系ビニルモノマーなどが好ましい。
又、ウレタンジメタクリレートやトリエチレングリコー
ルジメタクリレート等も好ましい。本発明の充填材料に
おける成分Aの含有割合は、成分Cの充填剤の含有割合
によって適宜選択されるが、一般的には充填材料全体の
20〜70重量%であることが好ましい。On the other hand, as the radically polymerizable monomer contained as the component A, various commercially available dental polymerizable resins can be used, but methacrylic acid ester vinyl monomers and acrylic acid ester vinyl monomers are preferable.
Further, urethane dimethacrylate, triethylene glycol dimethacrylate and the like are also preferable. The content ratio of the component A in the filling material of the present invention is appropriately selected according to the content ratio of the filler of the component C, but it is generally preferably 20 to 70% by weight based on the whole filling material.
【0010】更に、本発明における成分Bは、上述のラ
ジカル重合性単量体の重合を促進させるための光増感剤
(光重合触媒)であり、これまでに知られている市販品
が広く利用でき、例えばカンファーキノン等が好まし
い。この成分Bの、充填材料全体における含有割合は、
一般的には1重量%以下である。この他、本発明の歯牙
用光硬化性充填材料には、これまでに歯科用途において
知られている還元剤や安定剤が含有されても良い。Further, the component B in the present invention is a photosensitizer (photopolymerization catalyst) for accelerating the polymerization of the above-mentioned radical-polymerizable monomer, and commercially available products known so far are widely used. However, camphor quinone and the like are preferable. The content ratio of this component B in the whole filling material is
Generally, it is 1% by weight or less. In addition, the photo-curable filling material for teeth of the present invention may contain a reducing agent and a stabilizer known so far in dental applications.
【0011】尚、本発明の充填材料では、必須化合物で
ある酸化マグネシウムの以外に、充填剤として、硫酸バ
リウムを含有させるのが一般的であり、この場合には、
X線造影性が付与されたものとなる。本発明では、この
硫酸バリウムの代わりにフルオロアルミノシリケートガ
ラスなどが含有されても良く、この他にシリカやバリウ
ムガラス等が含有されても良い。The filling material of the present invention generally contains barium sulfate as a filler in addition to the essential compound magnesium oxide. In this case,
The X-ray contrast property is imparted. In the present invention, fluoroaluminosilicate glass or the like may be contained in place of the barium sulfate, and silica or barium glass or the like may be contained in addition thereto.
【0012】以下に実施例を挙げて本発明を更に具体的
に説明するが、本発明は、これに限定されるものではな
い。The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.
【実施例】以下の表1に記載される割合で各成分を混合
することにより、実施例1〜5に記載される組成を有す
る本発明の歯牙用光硬化性充填材料、及び、比較例に記
載される従来品(水酸化カルシウムを含有するもの)を
製造した。この際、酸化マグネシウム粉末としては、日
本薬局方の市販品(富田製薬株式会社製、軽質)を処理
せずに使用した。EXAMPLE A photocurable filling material for teeth of the present invention having the composition described in Examples 1 to 5 and a comparative example were prepared by mixing the components in the ratios shown in Table 1 below. The described conventional product (containing calcium hydroxide) was produced. At this time, as the magnesium oxide powder, a commercially available product of the Japanese Pharmacopoeia (Toda Pharmaceutical Co., Ltd., light quality) was used without treatment.
【0013】[0013]
【表1】 [Table 1]
【0014】そして、各充填材料を、それぞれ光を遮断
して室温下で保存し、製造(調合)1日後、3日後、1
週間後、1ヶ月後および3ヶ月後に、金型(直径3m
m、深さ12mmの円筒)の内部に充填し、上方部をカ
バーガラスで蓋をして、その上から可視光線(波長35
0〜700nm)を30秒間照射して硬化させた。硬化
後の各試料については、金型から製品を取り出し、未硬
化の部分を除去して、各充填材料についての硬化深度を
測定した。この実験結果を表2に示す。尚、硬化深度と
は、一定の光照射によって重合がどの程度深い部分にま
で達したかを示す値であり(単位:mm)、この値が大
きい程、充填材料の内部まで硬化可能で、重合性が良好
であることを示し、この値が小さいということは、充填
材料の表層部しか硬化せず、重合性が不良であることを
示す。Then, each of the filling materials is stored at room temperature while shielding the light, and after 1 day, 3 days after production (formulation),
After 1 week and 3 months, the mold (diameter 3m
m, cylinder with a depth of 12 mm), the upper part is covered with a cover glass, and visible light (wavelength 35
0 to 700 nm) for 30 seconds to cure. For each cured sample, the product was removed from the mold, the uncured portion was removed, and the cure depth for each fill material was measured. The results of this experiment are shown in Table 2. The curing depth is a value indicating how deep the polymerization reaches by constant light irradiation (unit: mm). The larger this value is, the more curable the inside of the filling material is. Indicates that the filling property is good, and that this value is small indicates that only the surface layer portion of the filling material is cured and the polymerizability is poor.
【0015】[0015]
【表2】 [Table 2]
【0016】表2に示されるように、本発明の歯牙用光
硬化性充填材料を用いた場合(実施例1〜5)では、製
造後(調合後)3ヶ月が経過した後であっても硬化深度
の低下が見られないことが確認された。これに対して、
水酸化カルシウムを含有する従来の充填剤の場合には、
製造して3ヶ月経過後において著しい硬化深度の低下が
確認され、充填材料の内部が硬化しにくくなることがわ
かった。As shown in Table 2, in the case where the photocurable filling material for teeth of the present invention is used (Examples 1 to 5), even after 3 months have passed since the production (after compounding). It was confirmed that no decrease in the curing depth was observed. On the contrary,
In the case of conventional fillers containing calcium hydroxide,
It was confirmed that the curing depth was remarkably lowered after 3 months from the production, and it was found that the inside of the filling material was hard to be cured.
【0017】同様に、前記実施例1〜5及び比較例に記
載される充填材料について、圧縮強度の経時変化を測定
した。この結果を以下の表3に示す。Similarly, with respect to the filling materials described in Examples 1 to 5 and Comparative Example, changes in compressive strength with time were measured. The results are shown in Table 3 below.
【0018】[0018]
【表3】 [Table 3]
【0019】表3に示されるように、本発明の歯牙用光
硬化性充填材料を用いた場合(実施例1〜5)では、製
造後3ヶ月が経過した後であっても硬化物の圧縮強度の
低下が見られないことが確認された。これに対して、水
酸化カルシウムを含有する従来の充填剤を用いて得られ
た硬化物の場合には、製造して1〜3ヶ月経過後におい
て著しい圧縮強度の低下が起こることが確認された。As shown in Table 3, when the photocurable filling material for teeth of the present invention is used (Examples 1 to 5), compression of the cured product is obtained even after 3 months from the production. It was confirmed that no decrease in strength was observed. On the other hand, in the case of a cured product obtained by using a conventional filler containing calcium hydroxide, it was confirmed that a significant decrease in compressive strength occurs after 1 to 3 months of production. .
【0020】[0020]
【発明の効果】本発明の歯牙用光硬化性充填材料は、強
アルカリ性である水酸化カルシウムを含まない代わり
に、これと同等の優れた歯髄保護効果を有する酸化マグ
ネシウムを含有するので、裏層剤や覆罩剤としての使用
に特に適している。そして、本発明の充填材料の場合に
は、樹脂の光硬化性が経時的に低下せず、得られる硬化
物の圧縮強度も経時的に劣化しないという優れた利点が
得られる。INDUSTRIAL APPLICABILITY The photocurable filling material for teeth of the present invention does not contain calcium hydroxide which is strongly alkaline, but contains magnesium oxide having an excellent pulp-protecting effect equivalent to that of calcium hydroxide. It is particularly suitable for use as an agent or a covering agent. Further, in the case of the filling material of the present invention, an excellent advantage that the photocurability of the resin does not decrease with time and the compression strength of the obtained cured product does not deteriorate with time is obtained.
Claims (1)
含むこと、及び、前記歯牙用光硬化性充填材料全体にお
ける前記酸化マグネシウム粉末の重量割合が2〜60重
量%であることを特徴とする歯牙用光硬化性充填材料。1. A photocurable filling material for teeth comprising a component A: a radically polymerizable unsaturated monomer, a component B: a photosensitizer, and a component C: a filler, wherein the component C is at least magnesium oxide. A photocurable filling material for teeth, comprising a powder, and the weight ratio of the magnesium oxide powder in the entire photocurable filling material for teeth is 2 to 60% by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5222133A JPH0753323A (en) | 1993-08-12 | 1993-08-12 | Photosetting packing material for tooth |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5222133A JPH0753323A (en) | 1993-08-12 | 1993-08-12 | Photosetting packing material for tooth |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0753323A true JPH0753323A (en) | 1995-02-28 |
Family
ID=16777692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5222133A Pending JPH0753323A (en) | 1993-08-12 | 1993-08-12 | Photosetting packing material for tooth |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0753323A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009209048A (en) * | 2008-02-29 | 2009-09-17 | Tomita Pharmaceutical Co Ltd | Medicinal magnesium oxide |
-
1993
- 1993-08-12 JP JP5222133A patent/JPH0753323A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009209048A (en) * | 2008-02-29 | 2009-09-17 | Tomita Pharmaceutical Co Ltd | Medicinal magnesium oxide |
JP4714929B2 (en) * | 2008-02-29 | 2011-07-06 | 富田製薬株式会社 | Acid-labile drug stabilizers |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9452112B2 (en) | Dental compositions | |
US4372836A (en) | Light curable acrylic dental composition with calcium fluoride pigment | |
JP2002512635A (en) | Dental restorative composition | |
CN1646077A (en) | Medical compositions containing an ionic salt | |
KR101979874B1 (en) | Manufacturing method of composite resin compositions for dental restoration comprising caprylic acid and composite resin compositions for dental restoration manufactured by the method | |
US4394465A (en) | Dental materials based on organic plastics in paste form | |
JP2002029912A (en) | Photopolymerizable composite resin composition for dental restoration | |
KR102698521B1 (en) | Resin block for dental cutting processing | |
US5662886A (en) | Adhesive amalgam system | |
JP3419488B2 (en) | Photopolymerizable dental composition | |
JP4148334B2 (en) | Light-curing dental restoration material | |
JPH0753323A (en) | Photosetting packing material for tooth | |
Dogon | Present and future value of dental composite materials and sealants | |
GB2094326A (en) | Resin-calcium hydroxide composite restorative dental material | |
JP4148332B2 (en) | Light-curing dental restoration material | |
EP2236122B1 (en) | Polymer-modified glass ionomer cement | |
EP4082514A1 (en) | Paste-like composition for dental use, and method for producing the same | |
JP3645722B2 (en) | Medical curable composition | |
KR100854955B1 (en) | Composition for Dental Materials | |
JPH0581563B2 (en) | ||
Yee et al. | Intermediate restorative materials | |
JP2022515851A (en) | Dental coating composition and dental materials containing it | |
KR102712379B1 (en) | Composite resin compositions including Lysozyme with improved antibio fuction and depth of polymerization and manufacturing method thereof | |
JP5882082B2 (en) | Photopolymerizable composition | |
JPH0669928B2 (en) | Photopolymerizable dental material |